Nashwa Amin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nashwa Amin has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Marong Fang
Department of Orthopedics, Children's Hospital, Zhejiang university school of medicine, National Clinical Research Center for Children and Adolescents' Health and Diseases, Hangzhou 310052, China; Institute of System Medicine, Zhejiang University School of Medicine, Hangzhou, China
3 shared publications Qiannan Ren
Institute of Neuroscience and Gastrointestinal Laboratory, The children's Hospital, Zhejiang University School of Medicine, Hangzhou, China
3 shared publicationsXiaoning Tan
Institute of Neuroscience and Gastrointestinal Laboratory, The children's Hospital, Zhejiang University School of Medicine, Hangzhou, China
3 shared publications- Zhiying Hu
Obstetrics & Gynecology Department, Zhejiang Integrated Traditional and Western Medicine Hospital, Hangzhou, China
3 shared publications Benson O.A. Botchway
Institute of Neuroscience and Gastrointestinal Laboratory, The children's Hospital, Zhejiang University School of Medicine, Hangzhou, China
2 shared publicationsAzhar B. Hussein
Institute of System Medicine, Zhejiang University School of Medicine, Hangzhou, China
1 shared publication
Latest Publications
- 12 September 2025
- Published by Elsevier in Behavioural Brain Research
- Vol. 496, 115821
High-dose subacute and acute thymoquinone treatments alleviate LPS-induced depressive-like behavior in mice by reducing inflammation via the IDO/KYN pathway
- 12 September 2025
- Published by Elsevier in Behavioural Brain Research
- Vol. 496, 115821
High-dose subacute and acute thymoquinone treatments alleviate LPS-induced depressive-like behavior in mice by reducing inflammation via the IDO/KYN pathway
- 5 February 2024
- Published by Elsevier in NeuroToxicology
- Vol. 101, 54-67
Thymoquinone regulates microglial M1/M2 polarization after cerebral ischemia-reperfusion injury via the TLR4 signaling pathway
- 5 February 2024
- Published by Elsevier in NeuroToxicology
- Vol. 101, 54-67
Thymoquinone regulates microglial M1/M2 polarization after cerebral ischemia-reperfusion injury via the TLR4 signaling pathway
- Open Access
- 5 December 2019
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 10, 1289
SIRT1 Protects Against Apoptosis by Promoting Autophagy in the Oxygen Glucose Deprivation/Reperfusion-Induced Injury
Silent information regulator 1 (SIRT1) contributes to cellular regulation. Previous studies have reported SIRT1 to be abnormally expressed in the ischemic penumbra of cerebral ischemia/reperfusion (I/R) injury rat model. We investigated the effect of SIRT1 on oxygen and glucose deprivation/reperfusion (OGD/R) cell injury. Over-expressed or silenced SIRT1 pheochromocytoma 12 (PC12) cells were exposed to an in-vitro OGD/R injury. Western blot, TUNEL staining and immunofluorescence analyses were performed to assess apoptosis and autophagy. We found autophagy and apoptosis to be up-regulated and down-regulated, respectively, following the over-expression of SIRT1 in the OGD/R-induced PC12 cells. We also found the silencing of SIRT1 to culminate in the down-regulation and up-regulation of autophagy and apoptosis, respectively. On the basis of our results, we surmise that SIRT1 can promote autophagy and inhibit apoptosis in-vitro, and thus exhibit potential neuroprotection against OGD/R-induced injury. This could facilitate in the development of therapeutic approaches for cerebral I/R injury.
- 5 December 2019
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 10, 1289
Open AccessSIRT1 Protects Against Apoptosis by Promoting Autophagy in the Oxygen Glucose Deprivation/Reperfusion-Induced Injury
Silent information regulator 1 (SIRT1) contributes to cellular regulation. Previous studies have reported SIRT1 to be abnormally expressed in the ischemic penumbra of cerebral ischemia/reperfusion (I/R) injury rat model. We investigated the effect of SIRT1 on oxygen and glucose deprivation/reperfusion (OGD/R) cell injury. Over-expressed or silenced SIRT1 pheochromocytoma 12 (PC12) cells were exposed to an in-vitro OGD/R injury. Western blot, TUNEL staining and immunofluorescence analyses were performed to assess apoptosis and autophagy. We found autophagy and apoptosis to be up-regulated and down-regulated, respectively, following the over-expression of SIRT1 in the OGD/R-induced PC12 cells. We also found the silencing of SIRT1 to culminate in the down-regulation and up-regulation of autophagy and apoptosis, respectively. On the basis of our results, we surmise that SIRT1 can promote autophagy and inhibit apoptosis in-vitro, and thus exhibit potential neuroprotection against OGD/R-induced injury. This could facilitate in the development of therapeutic approaches for cerebral I/R injury.
- 1 December 2019
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 95, 109674
Recent advances of induced pluripotent stem cells application in neurodegenerative diseases
- 1 December 2019
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 95, 109674
Recent advances of induced pluripotent stem cells application in neurodegenerative diseases